Psorizide Forte NDC 61480-255

NDC codes

FDA NDC Directory

Product NDC (as listed)61480-255Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61480-0255Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
61480-255-05	61480025505	90 TABLET in 1 BOTTLE (61480-255-05)Marketed from Nov 15, 2001

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Psorizide Forte
Generic name (nonproprietary): nickel sulfate, potassium bromide, and fumaric acid
Active ingredients: Nickel sulfate — 1 [hp_X]/1Potassium bromide — 1 [hp_X]/1Fumaric acid — 1 [hp_X]/1
Dosage form: Tablet
Route: Oral
Labeler: PLYMOUTH HEALTHCARE PRODUCTS LLC
Product type: Prescription drug
Marketing category: Unapproved homeopathic
Marketing start: Nov 15, 2001
Listing expires: Dec 31, 2026
Identifiers: Product ID 61480-255_440c889d-1e85-767e-e063-6394a90abaa8SPL ID 440c889d-1e85-767e-e063-6394a90abaa8SPL set ID 7896794a-60bd-4dfa-abfe-aa29aaa6f74dUNII 4FLT4T3WUN, OSD78555ZM, 88XHZ13131

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N461480025505 followed by a unit qualifier and the quantity

Package 61480-0255-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 20, 2025.

Indications (excerpt from the label)

INDICATIONS PSORIZIDE ® Forte is indicated for the treatment of contact dermatitis due to nickel (metal/jewelry allergy,) dyshidrotic hand/foot eczema, and mild to severe psoriasis. It has been found to work well with a variety of combination therapies. Eczema, seborrhea and a variety of chronic pruritic inflammatory dermatoses generally respond well also.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)